The eNOS-inhibitors OPG and ADMA are elevated in both falciparum and knowlesi malaria (Yeo et al., 2010; Barber et al., 2021), and both are associated with eGC degradation in malaria (Barber et al., 2021). Here, NOS3 is linked to malaria.